Wednesday, February 24, 2021
Home Corona Virus WHO halts trial of hydroxychloroquine, says corona failed to reduce patients mortality

WHO halts trial of hydroxychloroquine, says corona failed to reduce patients mortality

Ahmedabad: The World Health Organization (WHO) said on Saturday that it is stopping the trial of the malaria drug hydroxychloroquine given to corona-infected patients simultaneously. This is being done because the effect of both the drugs has failed to reduce the mortality rate of corona infected patients. 

The WHO said that for the first time in a single day, the organization has been shocked when the number of more than two lakh Korana patients worldwide reaches. Out of a total of 2,12,326 in the United States, 53,213 new cases were registered on Friday.

The WHO said that given the standards of patients being corrected, hydroxychloroquine and lopinavir/ritonavir are not the right standards. The results of the interim test of Ratanvir indicate that the pace of reduction in mortality of infected patients was very low or there was no decrease. The situation will unite and disrupt the investigators involved in the trial with immediate effect.

The UN agency said that the decision has been taken on the recommendation of the International Steering Committee of testing for hydroxychloroquine tablets. The agency made it clear that the decision would not affect other studies. Nor will the use of hydroxychloroquine affect patients admitted in non-hospitals.

Coronavirus Vaccine Updates

There is a competition to make the first vaccine of corona virus all over the world. Almost all the big countries are claiming that they will bring the first vaccine by the end of this year, which can control the corona. This is about the world’s prestigious virus expert Pro. Peter Pout says the corona vaccine alone will not be able to get rid of the epidemic. He explained the reason why it usually takes one-and-a-half years to become a vaccine and has a very low success rate.

Pro. Peter is dean of the London School of Hygiene and Tropical Medicine and was speaking as the keynote speaker at a webinar series organized by the National Institute of Singapore Yong Loo Lin School of Medicine on Friday. He said that it does not seem that in the coming few months, the vaccine can be prepared and distributed to crores of people in the world. At the same time, he cautioned that no shortcuts can be taken to make the Kovid vaccine, and some kind of haste can further reduce the impact of the vaccine.

Success rate of vaccine is only 10 percent

Professor Peter says that the vaccine’s success rate is usually only ten per cent, but he believes that if the corona’s potential vaccine is 70 per cent effective, it will be a great success.

Who is Professor Peter ?

Professor Peter was the leading scientist in the Ebola virus search team. He has been a pioneer in the global fight against HIV.

Long-lasting rescue methods have to be adopted

He was in the grip of corona infection during his study and could recover after three months. He says that the corona is a very dangerous virus, it affects the whole body, not the heart itself.

Medicines used in India to treat COVID-19 patients


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Popular